Toxicity of chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in diethylnitrosamine-initiated ovariectomized rats implanted with subcutaneous 17 β-estradiol pellets

Toxicological Sciences

Volumn 54, Issue 2, 2000, Pages 493-499

  Wyde, Michael E ^a,b   Seely, John ^c   Lucier, George W ^b   Walker, Nigel J ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c PATHCO Inc   (United States)

Author keywords

17 estradiol; 2,3,7,8 tetrachlorodibenzo p dioxin; Clinical chemistry; Hepatocarcinogenesis; Subcutaneous pellets

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; DIETHYLNITROSAMINE; ESTRADIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHRONIC TOXICITY; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; IMPLANTATION; LIVER CARCINOGENESIS; LIVER TOXICITY; LONG TERM EXPOSURE; NONHUMAN; OVARIECTOMY; RAT; UTERUS WEIGHT;

ANIMALS; BODY WEIGHT; CLINICAL CHEMISTRY TESTS; COCARCINOGENESIS; DIETHYLNITROSAMINE; DRUG IMPLANTS; ENVIRONMENTAL POLLUTANTS; ESTRADIOL; FEMALE; LIVER; ORGAN SIZE; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; TETRACHLORODIBENZODIOXIN; UTERUS;

ANIMALIA;

EID: 0034033887     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bagi, C., van der Meulen, M., Brommage, R., Rosen, D., and Sommer, A. (1995). The effect of systemically administered rhIGF-1/IGFBP-3 complex on cortical bone strength and structure in ovariectomized rats. Bone 16, 559-565.
2. Bertazzi, P. A., Bernucci, I., Brambilla, G., Consonni, D., and Pesatori, A. C. (1998). The Seveso studies on early and long-term effects of dioxin exposure: A review. Environ. Health Perspect. 106(Suppl. 2), 625-633.
3. Clark, R. G., and Tarttelin, M. F. (1982). Some effects of ovariectomy and estrogen replacement on body composition in the rat. Physiol. Behav. 28, 963-969.
4. Clark, G., Tritscher, A., Maronpot, R., Foley, J., and Lucier, G. (1991). Tumor promotion by TCDD in female rats. Banbury Report 35: Biological Basis for Risk Assessment of Dioxins and Related Compounds. (M. A. Gallo, R. J. Scheuplein, and K. A. Van Der Heijden, Eds.). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
5. DeVito, M. J., Thomas, T., Martin, E., Umbreit, T. H., and Gallo, M. A. (1992). Antiestrogenic action of 2,3,7,8-tetrachlorodibenzo-p-dioxin: Tissue-specific regulation of estrogen receptor in CD1 mice. Toxicol. Appl. Pharmacol. 113, 284-292.
6. Graham, M. J., Lucier, G. W., Linko, P., Maronpot, R. R., and Goldstein, J. A. (1988). Increases in cytochrome P-450-mediated 17 β-estradiol 2-hydroxylase activity in rat liver microsomes after both acute administration and subchronic administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin in a two-stage hepatocarcinogenesis model. Carcinogenesis 9, 1935-1941.
7. Harris, M. W., Moore, J. A., Vos, J. G., and Gupta, B. N. (1973). General biological effects of TCDD in laboratory animals. Environ. Health Perspect. 5, 101-109.
8. Huff, J., Lucier, G., and Tritscher, A. (1994). Carcinogenicity of TCDD: Experimental, mechanistic, and epidemiologic evidence. Annu. Rev. Pharmacol. Toxicol. 34, 343-372.
9. Kociba, R. (1984). Evaluation of the carcinogenic and mutant potential of 2,3,7,8-TCDD and other chlorinated dioxins. Bio. Mech. Dioxin Action 18, 73-84.
10. Kociba, R. J., Keeler, P. A., Park, C. N., and Gehring, P. J. (1976). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD): Results of a 13-week oral toxicity study in rats. Toxicol. Appl. Pharmacol. 35, 553-574.
11. Kociba, R. J., Keyes, D. G., Beyer, J. E., Carreon, R. M., Wade, C. E., Dittenber, D. A., Kalnins, R. P., Frauson, L. E., Park, C. N., Barnard, S. D., Hummel, R. A., and Humiston, C. G. (1978). Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol. Appl. Pharmacol. 46, 279-303.
12. Kociba, R. J., and Schwetz, B. A. (1982). Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Drug Metab. Rev. 13, 387-406.
13. Lucier, G. W., Tritscher, A. M., Goldsworthy, T., Foley, J., Clark, G., Goldstein, J., and Maronpot, R. (1991). Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis. Cancer Res. 51, 1391-1397.
14. MacKenzie, S. A., Thomas, T., Umbreit, T. H., and Gallo, M. A. (1992). The potentiation of 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity by tamoxifen in female CD1 mice. Toxicol. Appl. Pharmacol. 116, 101-109.
15. Martucci, C. P., and Fishman, J. (1993). P450 enzymes of estrogen metabolism. Pharmacol. Ther. 57, 237-257.
16. National Toxicology Program (1982). Bioassay of 2,3,7,8-tetrachlorodibenzo-p-dioxin for possible carcinogenicity (gavage study). NTP TR 201. National Toxicology Program, U.S. Department of Health and Human Services, Research Triangle Park. NC.
17. Overpeck, J. G., Colson, S. H., Hohmann, J. R., Applestine, M. S., and Reilly, J. F. (1978). Concentrations of circulating steroids in normal prepubertal and adult male and female humans, chimpanzees, rhesus monkeys, rats, mice, and hamsters: Literature survey. J. Toxicol. Environ. Health 4, 785-803.
18. Pilot, H., Goldsworthy, T., Campbell, H., and Poland, A. (1980). Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzp-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. Cancer Res. 40, 3616-3620.
19. Pohjanvirta, R., and Tuomisto, J. (1994). Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: Effects, mechanisms, and animal models. Pharmacol. Rev. 46, 483-549.
20. Poland, A., and Glover, E. (1979). An estimate of the maximum in vivo covalent binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin to rat protein, ribosomal RNA, and DNA. Cancer Res. 39, 3341-3344.
21. Poland, A., and Knutson, J. C. (1982). 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: Examination of the mechanism toxicity. Annu. Rev. Pharmacol. Toxicol. 22, 517-554.
22. Poland, A., Palen, D., and Glover, E. (1982). Tumor promotion by TCDD in skin of HRS/J hairless mice. Nature 300, 271-273.
23. Ryan, D. E., Ilida, S., Wood, A. W., Thomas, P. E., Lieber, C. S., and Levin, W. (1984). Characterization of three highly purified cytochromes P450 from hepatic microsomes of adult male rats. J. Biol. Chem. 259, 1239-1250.
24. Safe, S. H. (1995). Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol. Ther. 67, 247-281.
25. Schmidt, J. V., and Bradfield, C. A. (1996). Ah-receptor signaling pathways. Annu. Rev. Cell Dev. Biol. 12, 55-89.
26. Sewall, C. H., Lucier, G. W., Tritscher, A. M., and Clark, G. C. (1993). TCDD-mediated changes in hepatic epidermal-growth-factor receptor may be a critical event in the hepatocarcinogenic action of TCDD. Carcinogenesis 14, 1885-1893.
27. Shiverick, K. T., and Muther, T. F. (1983). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) effects on hepatic microsomal steroid metabolism and serum estradiol of pregnant rats. Biochem. Pharmacol. 32, 991-995.
28. Sutter, T. R. and Greenlee, W. F. (1992). Classification of Members of the Ah Gene Battery. Chemosphere 25, 223-226.
29. Swanson, H. I., and Bradfield, C. A. (1993). The Ah-receptor: Genetics, structure, and function. Pharmacogenetics 3, 213-230.
30. Tritscher, A. M., Seacat, A. M., Yager, J. D., Groopman, J. D., Miller, B. D., Bell, D., Sutter, T. R., and Lucier, G. W. (1996). Increased oxidative DNA damage in livers of 2,3,7,8-tetrachlorodibenzo-p-dioxin treated intact but not ovariectomized rats. Cancer Lett. 98, 219-225.
31. Umbreit, T. H., Scala, P. L., MacKenzie, S. A., and Gallo, M. A. (1989). Alteration of the acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) by estradiol and tamoxifen. Toxicology 59, 163-169.
32. Van den Heuvel, J. P., Clark, G. C., Tritscher, A. M., and Lucier, G. W. (1994). Accumulation of polychlorinated dibenzo-p-dioxins and dibenzofurans in liver of control laboratory rats. Fundam. Appl. Toxicol. 23, 465-469.
33. Wassom, J. S., Huff, J. E., and Loprieno, N. A. (1977). A review of the genetic toxicology of chlorinated dibenzo-p-dioxins. Mutat. Res. 47, 141-160.
34. Whitlock, J. P., Jr., Chichester, C. H., Bedgood, R. M., Okino, S. T., Ko, H. P., Ma, Q., Dong, L., Li, H., and Clarke-Katzenberg, R. (1997). Induction of drug-metabolizing enzymes by dioxin. Drug Metab. Rev. 29, 1107-1127.
35. Yager, J. D., and Liehr, J. G. (1996). Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 36, 203-232.